ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,755.40
-1.33%
S&P ASX All Technology
3,087.60
-0.48%
Brent Oil
81.415
-0.44%
US Dollar vs AUD
1.51469
0.08%
Bitcoin
67,540.59
-2.84%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) News

ENTA Enanta Pharmaceuticals Inc

12.78
0.00 (0.00%)
Pre Market
Last Updated: 18:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Enanta Pharmaceuticals Inc ENTA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 12.78 18:00:00
Open Price Low Price High Price Close Price Previous Close
12.78
more quote information »

Recent News

Date Time Source Heading
29/5/202421:00BWEnanta Pharmaceuticals to Participate at the Jefferies..
09/5/202406:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202406:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202421:00BWEnanta Pharmaceuticals to Participate at the JMP Securities..
07/5/202406:05EDGAR2Form 8-K - Current report
07/5/202406:01BWEnanta Pharmaceuticals Reports Financial Results for its..
30/4/202421:10BWEnanta Pharmaceuticals Announces Inducement Grants Under..
30/4/202421:00BWEnanta Pharmaceuticals Announces the Appointment of Matthew..
29/4/202421:00BWEnanta Pharmaceuticals to Host Conference Call on May 6 at..
17/4/202421:00BWEnanta Pharmaceuticals Announces Data Presentation at ESCMID..
09/3/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:00BWEnanta Pharmaceuticals to Participate at Leerink Partners..
28/2/202410:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202405:11EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202412:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202406:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202408:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/2/202408:05EDGAR2Form 8-K - Current report
08/2/202408:01BWEnanta Pharmaceuticals Reports Financial Results for its..
06/2/202423:00BWEnanta Pharmaceuticals to Participate at the Oppenheimer..
31/1/202423:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
27/1/202408:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/1/202408:25EDGAR2Form DEF 14A - Other definitive proxy statements
25/1/202409:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/1/202408:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202423:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
03/1/202423:00BWEnanta Pharmaceuticals to Present at the 42nd Annual J.P...
27/12/202308:06EDGAR2Form 8-K - Current report
16/12/202312:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:16EDGAR2Form 144 - Report of proposed sale of securities
07/12/202312:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202312:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202313:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202313:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
ENTA
Enanta Pharmaceuticals
LSE
MYX
Mycelx Technologies
KRKN
SUPERUSD
SuperFarm
LSE
H78
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved